Ownership

Lindsey Rolfe - Insider Trading & Ownership

Entity: Individual
Location: C/O Clovis Oncology, Inc., 499 Illinois Street, Suite 200, San Francisco, CA
Summary: The estimated net worth of Lindsey Rolfe is at least $112K dollars as of March 6, 2025. Lindsey Rolfe is the Officer of Clovis Oncology, Inc. and owns shares of Clovis Oncology, Inc. stock worth about $112K.
All Insider Reports: All Insider Reports

Ownership of Lindsey Rolfe

Symbol	Company	Relationship	Holdings Value	Report Period
CLVS	Clovis Oncology, Inc.	Officer	$112K	Nov 1, 2022
BCEL	Atreca, Inc.	Director		Jun 13, 2023
CERO, CEROW	CERO THERAPEUTICS HOLDINGS, INC.	Director		Mar 4, 2025

Showing 1 to 3 of 3 entries

Insider Transactions Reported by Lindsey Rolfe:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
CERO	Cero Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+17.9K	17.9K	3/4/2025	Direct
CERO	Cero Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Award	+100%	$0	0.00	+128K	255K	2/24/2025	Direct
CERO	Cero Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+128K	128K	12/2/2024	Direct
CERO	Cero Therapeutics Holdings, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+113K	113K	3/25/2024	Direct
BCEL	Atreca, Inc.	Stock Option (right to buy)	Award		$0	0.00	+12K	12K	6/13/2023	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-3.68%	-$4.19K	0.98^*	-4.26K	111K	11/2/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+7.78%	$0		+8.37K	116K	11/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-69.1%	$0	0.00	-8.37K	3.75K	11/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-2.27%	-$3.05K	1.20^*	-2.55K	110K	9/2/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+4.73%	$0		+5.06K	112K	9/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	+11.1%	$0	0.00	+5.06K	50.6K	9/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-3.97%	-$6.33K	1.46^*	-4.33K	105K	8/2/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+8.28%	$0		+8.37K	109K	8/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-52.8%	$0	0.00	-8.37K	7.5K	8/1/2022	Direct
BCEL	Atreca, Inc.	Stock Option (right to buy)	Award		$0	0.00	+12K	12K	6/8/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-2.51%	-$1.7K	0.64^*	-2.65K	103K	6/2/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+5.03%	$0		+5.06K	106K	6/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	+10%	$0	0.00	+5.06K	55.7K	6/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-4.15%	-$8.38K	1.97^*	-4.25K	98.3K	5/2/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+8.85%	$0		+8.37K	103K	5/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-42.7%	$0	0.00	-8.37K	11.2K	5/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-11.2%	-$20.4K	1.87^*	-10.9K	86.8K	3/2/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+24.3%	$0		+20.9K	107K	3/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	+50%	$0	0.00	+20.3K	60.8K	3/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise		$0	0.00^*	+688	0	3/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Award		$0	0.00	+81K	81K	3/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-5.08%	-$8.76K	1.94^*	-4.51K	84.4K	2/2/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+10.4%	$0		+8.38K	89K	2/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-35.8%	$0	0.00	-8.38K	15K	2/1/2022	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-0.42%	-$1.04K	3.00^*	-346	82.6K	12/2/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+0.83%	$0		+687	83K	12/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-50%	$0	0.00	-687	688	12/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-5%	-$19.2K	4.55^*	-4.21K	80K	11/2/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+11%	$0		+8.37K	84.6K	11/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-30.9%	$0	0.00	-8.37K	18.7K	11/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-0.44%	-$1.7K	4.89^*	-347	78.1K	9/2/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+0.88%	$0		+688	78.5K	9/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-33.3%	$0	0.00	-688	1.38K	9/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-5.27%	-$20.2K	4.82^*	-4.2K	75.5K	8/3/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+11.7%	$0		+8.37K	80.1K	8/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	-27.1%	$0	0.00	-8.37K	22.5K	8/1/2021	Direct
BCEL	Atreca, Inc.	Stock Option (right to buy)	Award		$0	0.00	+12K	12K	6/9/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Sale	-0.44%	-$1.81K	5.63^*	-322	73.6K	6/3/2021	Direct
CLVS	Clovis Oncology, Inc.	Common Stock	Options Exercise	+0.94%	$0		+687	73.9K	6/1/2021	Direct
CLVS	Clovis Oncology, Inc.	Restricted Stock Units	Options Exercise	+49.9%	$0	0.00	+687	2.06K	6/1/2021	Direct

Previous1Next

Showing 1 to 45 of 45 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.